Trial Profile
Efficacy and tolerability of recombinant human endostatin in combination with platinum-based chemotherapy in patients with advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Mar 2010
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Antineoplastics
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 Mar 2010 Status changed to completed, as reported by a Simcere media release.
- 03 Sep 2008 Interim results reported in a Simcere media release.
- 03 Sep 2008 New trial record.